Sutro Biopharma (STRO) Amortizatization of Intangibles (2017 - 2025)

Sutro Biopharma has disclosed Amortizatization of Intangibles across 9 years of filings, most recently posting $531000.0 for Q4 2025.

• Amortizatization of Intangibles for Q4 2025 came in at $531000.0, down 65.5% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.4 million (down 64.66% YoY), and the FY2025 annual result was $3.4 million, down 64.66% from the prior year.
• Amortizatization of Intangibles came in at $531000.0 for Q4 2025 at Sutro Biopharma, down from $755000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $3.1 million in Q4 2023 to a low of -$799000.0 in Q4 2021.
• The 5-year median for Amortizatization of Intangibles is $1.1 million (2025), against an average of $990600.0.
• Across the five-year window, Amortizatization of Intangibles plunged 1309.76% in 2021 and soared 2224.27% in 2023, its largest moves.
• Sutro Biopharma's Amortizatization of Intangibles stood at -$799000.0 in 2021, then soared by 246.93% to $1.2 million in 2022, then soared by 160.05% to $3.1 million in 2023, then plunged by 49.59% to $1.5 million in 2024, then sank by 65.5% to $531000.0 in 2025.
• The last three Amortizatization of Intangibles figures came in at $531000.0 (Q4 2025), $755000.0 (Q3 2025), and $1.0 million (Q2 2025), per Business Quant data.